Chromosomal instability and transcriptome dynamics in cancer

Cancer and Metastasis Reviews

Volumn 32, Issue 3-4, 2013, Pages 391-402

  Stevens, Joshua B ^a   Horne, Steven D ^a   Abdallah, Batoul Y ^a   Ye, Christine J ^a   Heng, Henry H ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

CCA; Clonal chromosome aberration; Genome chaos; Genomic instability; Karyotypic heterogeneity; NCCA; Network dynamics; Nonclonal chromosome aberration; Punctuated phase of cancer evolution; Transcriptome

Indexed keywords

MESSENGER RNA; PROTEIN P53; TRANSCRIPTOME;

ARTICLE; CANCER CELL CULTURE; CANCER RESEARCH; CHROMOSOMAL INSTABILITY; CHROMOSOME; CHROMOSOME ABERRATION; CLONAL CHROMOSOME ABERRATION; COLORECTAL TUMOR; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; HUMAN; KARYOTYPE; METASTASIS; MOLECULAR DYNAMICS; NONCLONAL CHROMOSOME ABERRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH TUMOR; TRISOMY 21; TUMOR INVASION;

ANIMALS; CHROMOSOMAL INSTABILITY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC HETEROGENEITY; GENOMIC INSTABILITY; HUMANS; KARYOTYPE; NEOPLASMS; TRANSCRIPTOME;

EID: 84890310818     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-013-9428-6     Document Type: Article

References (78)

1. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
2. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2000). Molecular portraits of human breast tumours. Nature, 406, 747-752.
3. Rimm, D. L. (2000). Molecular biology in cytopathology: current applications and future directions. Cancer, 90, 1-9.
4. van't Veer, L. J., Dai, H. Y., van de Vijver, M. J., He, Y. D. D., Hart, A. A. M., et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
5. Buyse, M., Loi, S., van't Veer, L., Viale, G., Delorenzi, M., et al. (2006). Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Nat Cancer Inst, 98, 1183-1192.
6. Lehmann, T., & Wrzesinski, T. (2012). The molecular basis of adrenocortical cancer. Cancer Genet, 205, 131-137.
7. Lucas, S. M., & Heath, E. I. (2012). Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers. Prostate Cancer, 2012, 640968.
8. Simon, R., Radmacher, M. D., Dobbin, K., & McShane, L. M. (2003). Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. Journal of the National Cancer Institute, 95, 14-18.
9. Ein-Dor, L., Zuk, O., & Domany, E. (2006). Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proceedings of the National Academy of Sciences of the United States of America, 103, 5923-5928.
10. Venet, D., Dumont, J. E., & Detours, V. (2011). Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Computational Biology, 7, e1002240.
11. Kitano, H. (2002). Systems biology: a brief overview. Science, 295, 1662-1664.
12. Cancer Genome Atlas Research Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489: 519-525.
13. Brock, A., Chang, H., & Huang, S. (2009). Non-genetic heterogeneity - a mutation-independent driving force for the somatic evolution of tumours. Nature Reviews Genetics, 10, 336-342.
14. Yurov, Y. B., Iourov, I. Y., Monakhov, V. V., Soloviev, I. V., Vostrikov, V. M., et al. (2005). The variation of aneuploidy frequency in the developing and adult human brain revealed by an interphase FISH study. Journal of Histochemistry and Cytochemistry, 53, 385-390.
15. Heng, H. H. (2013). Biocomplexity: challenging reductionism. In J. P. Sturmberg & C. C. Martin (Eds.), Handbook on systems and complexity in health. London: Springer.
16. Duncan, A. W., Hanlon Newell, A. E., Smith, L., Wilson, E. M., Olson, S. B., et al. (2012). Frequent aneuploidy among normal human hepatocytes. Gastroenterology, 142, 25-28.
17. Rehen, S. K., Yung, Y. C., McCreight, M. P., Kaushal, D., Yang, A. H., et al. (2005). Constitutional aneuploidy in the normal human brain. Journal Neurosci, 25, 2176-2180.
18. Iourov, I. Y., Vorsanova, S. G., & Yurov, Y. B. (2008). Chromosomal mosaicism goes global. Molecular Cytogen, 1, 26.
19. Stevens, J.B., Abdallah, B.Y., Horne, S.D., Liu, G., Bremer, S.W., et al. (2011). Genetic and epigenetic heterogeneity in cancer. encyclopedia of life sciences. New York: Wiley
20. Heng, H. H., Stevens, J. B., Bremer, S. W., Liu, G., Abdallah, B. Y., et al. (2011). Evolutionary mechanisms and diversity in cancer. Advances in Cancer Research, 112, 217-253.
21. Heng, H. H., Liu, G., Stevens, J. B., Bremer, S. W., Ye, K. J., et al. (2010). Genetic and epigenetic heterogeneity in cancer: the ultimate challenge for drug therapy. Current Drug Targets, 11, 1304-1316.
22. Bielas, J. H., & Loeb, L. A. (2005). Quantification of random genomic mutations. Nature Methods, 2, 285-290.
23. Gao, C., Furge, K., Koeman, J., Dykema, K., Su, Y., et al. (2007). Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proceedings of the National Academy of Sciences of the United States of America, 104, 8995-9000.
24. Tsafrir, D., Bacolod, M., Selvanayagam, Z., Tsafrir, I., Shia, J., et al. (2006). Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Research, 66, 2129-2137.
25. Cheng, L., Wang, P., Yang, S., Yang, Y., Zhang, Q., et al. (2012). Identification of genes with a correlation between copy number and expression in gastric cancer. BMC Medical Genomics, 5, 14.
26. Heng, H. H., Liu, G., Stevens, J. B., Bremer, S. W., Ye, K. J., et al. (2011). Decoding the genome beyond sequencing: the new phase of genomic research. Genomics, 98, 242-252.
27. Heng, H. H., Stevens, J. B., Liu, G., Bremer, S. W., Ye, K. J., et al. (2006). Stochastic cancer progression driven by non-clonal chromosome aberrations. Journal of Cellular Physiology, 208, 461-472.
28. Heng, H. H., Bremer, S. W., Stevens, J., Ye, K. J., Miller, F., et al. (2006). Cancer progression by non-clonal chromosome aberrations. Journal of Cellular Biochemistry, 98, 1424-1435.
29. Creekmore, A. L., Silkworth, W. T., Cimini, D., Jensen, R. V., Roberts, P. C., et al. (2011). Changes in gene expression and cellular architecture in an ovarian cancer progression model. PloS One, 6, e17676.
30. Lawrenson, L. (2010). Tracking profiles of genomic instability in spontaneous transformation and tumorigenesis. Detroit: Wayne State University School of Medicine.
31. Okamura, K., Feuk, L., Marques-Bonet, T., Navarro, A., & Scherer, S. W. (2006). Frequent appearance of novel protein-coding sequences by frameshift translation. Genomics, 88, 690-697.
32. Nicke, B., Bastien, J., Khanna, S. J., Warne, P. H., Cowling, V., et al. (2005). Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Molecular Cell, 20, 673-685.
33. Roberts, P. C., Mottillo, E. P., Baxa, A. C., Heng, H. H., Doyon-Reale, N., et al. (2005). Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model. Neoplasia, 7, 944-956.
34. Pavelka, N., Rancati, G., Zhu, J., Bradford, W. D., Saraf, A., et al. (2010). Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature, 468, 321-325.
35. Rancati, G., Pavelka, N., Fleharty, B., Noll, A., Trimble, R., et al. (2008). Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell, 135, 879-893.
36. Springer, M., Weissman, J. S., & Kirschner, M. W. (2010). A general lack of compensation for gene dosage in yeast. Mol Sys Biol, 6, 368.
37. Sheltzer, J. M., Torres, E. M., Dunham, M. J., & Amon, A. (2012). Transcriptional consequences of aneuploidy. Proceedings of the National Academy of Sciences, 109, 12644-12649.
38. FitzPatrick, D. R., Ramsay, J., McGill, N. I., Shade, M., Carothers, A. D., et al. (2002). Transcriptome analysis of human autosomal trisomy. Human Molecular Genetics, 11, 3249-3256.
39. Ait Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., et al. (2007). Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. American Journal of Human Genetics, 81, 475-491.
40. Stingele, S., Stoehr, G., Peplowska, K., Cox, J., Mann, M., et al. (2012). Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Molecular Systems Biology, 8, 608.
41. Kuijjer, M. L., Rydbeck, H., Kresse, S. H., Buddingh, E. P., Lid, A. B., et al. (2012). Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Genes, Chromosomes & Cancer, 51, 696-706.
42. Huang, S. (2009). Non-genetic heterogeneity of cells in development: more than just noise. Development, 136, 3853-3862.
43. Chang, H. H., Hemberg, M., Barahona, M., Ingber, D. E., & Huang, S. (2008). Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature, 453, 544-547.
44. Ye, C. J., Stevens, J. B., Liu, G., Bremer, S. W., Jaiswal, A. S., et al. (2009). Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer. Journal of Cellular Physiology, 219, 288-300.
45. Mi, R., Pan, C., Bian, X., Song, L., Tian, W., et al. (2012). Fusion between tumor cells enhances melanoma metastatic potential. Journal of Cancer Research and Clinical Oncology, 138, 1651-1658.
46. Pinto, A. E., Silva, G. L., Pereira, T., Cabrera, R. A., Santos, J. R., et al. (2012). S-phase fraction and ploidy as predictive markers in primary disease and recurrence of papillary thyroid carcinoma. Clinical Endocrinology, 77, 302-309.
47. Jasmine, F., Rahaman, R., Dodsworth, C., Roy, S., Paul, R., et al. (2012). A genome-wide study of cytogenetic changes in colorectal cancer using snp microarrays: opportunities for future personalized treatment. PloS One, 7, e31968.
48. Duesberg, P., Li, R., Fabarius, A., & Hehlmann, R. (2006). Aneuploidy and cancer: from correlation to causation. Contributions to Microbiology, 13, 16-44.
49. Braun, S., Auer, D., & Marth, C. (2009). The prognostic impact of bone marrow micrometastases in women with breast cancer. Cancer Investigation, 27, 598-603.
50. Habermann, J. K., Paulsen, U., Roblick, U. J., Upender, M. B., McShane, L. M., et al. (2007). Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes, Chromosomes & Cancer, 46, 10-26.
51. Lu, X., Lu, X., & Kang, Y. (2010). Organ-specific enhancement of metastasis by spontaneous ploidy duplication and cell size enlargement. Cell Research, 20, 1012-1022.
52. Adeyinka, A., Kytola, S., Mertens, F., Pandis, N., & Larsson, C. (2000). Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases. International Journal of Molecular Medicine, 5, 235-240.
53. Popescu, N. C., & Zimonjic, D. B. (2002). Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy. American Journal of Medical Genetics, 115, 142-149.
54. Bieche, I., & Lidereau, R. (1995). Genetic alterations in breast-cancer. Genes, Chromosomes & Cancer, 14, 227-251.
55. Goodison, S., Viars, C., & Urquidi, V. (2005). Molecular cytogenetic analysis of a human breast metastasis model: identification of phenotype-specific chromosomal rearrangements. Cancer Genetics and Cytogenetics, 156, 37-48.
56. Klein, C. A., Blankenstein, T. J., Schmidt-Kittler, O., Petronio, M., Polzer, B., et al. (2002). Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet, 360, 683-689.
57. Malkhosyan, S., Yasuda, J., Soto, J. L., Sekiya, T., Yokota, J., et al. (1998). Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proceedings of the National Academy of Sciences of the United States of America, 95, 10170-10175.
58. Barbazan, J., Alonso-Alconada, L., Muinelo-Romay, L., Vieito, M., Abalo, A., et al. (2012). Molecular characterization of circulating tumor cells in human metastatic colorectal cancer. PloS One, 7, e40476.
59. Gupta, G. P., Nguyen, D. X., Chiang, A. C., Bos, P. D., Kim, J. Y., et al. (2007). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature, 446, 765-770.
60. Lunt, S. J., Chaudary, N., & Hill, R. P. (2009). The tumor microenvironment and metastatic disease. Clinical & Experimental Metastasis, 26, 19-34.
61. Ellsworth, R., Ellsworth, D., Patney, H., Deyarmin, B., Hooke, J., et al. (2008). Genomic alterations associated with early stages of breast tumor metastasis. Annals of Surgical Oncology, 15, 1989-1995.
62. Heng, H.H., Bremer, S.W., Stevens, J.B., Horne, S.D., Liu, G., et al. (2013). Chromosomal instability (CIN): what is it and why it is crucial to cancer evolution. Cancer and Metastasis Reviews (in press).
63. Sethi, N., & Kang, Y. (2011). Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nature Reviews Cancer, 11, 735-748.
64. Frost, P., Kerbel, R. S., Hunt, B., Man, S., & Pathak, S. (1987). Selection of metastatic variants with identifiable karyotypic changes from a nonmetastatic murine tumor after treatment with 2′-deoxy-5-azacytidine or hydroxyurea: implications for the mechanisms of tumor progression. Cancer Research, 47, 2690-2695.
65. Ince, T. A., Richardson, A. L., Bell, G. W., Saitoh, M., Godar, S., et al. (2007). Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell, 12, 160-170.
66. Ton, N. C., & Jayson, G. C. (2004). Resistance to anti-VEGF agents. Current Pharmaceutical Design, 10, 51-64.
67. Horne, S.D., Stevens, J.B., Abdallah, B.Y., Liu, G., Bremer, S.W., et al. (2013). Why Gleevec remains the exception of cancer research - a genome-based evolutionary perspective. Journal of Cellular Physiology 228:665-670
68. Higgins, C. F. (2007). Multiple molecular mechanisms for multidrug resistance transporters. Nature, 446, 749-757.
69. Duesberg, P., Stindl, R., & Hehlmann, R. (2001). Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy. Proceedings of the National Academy of Sciences of the United States of America, 98, 11283-11288.
70. Heng, H.H., Liu, G., Stevens, J.B., Abdallah, B.Y., Horne, S.D., et al. (2013). Karyotype heterogeneity and unclassified chromosomal abnormalities. Cytogenetic and Genome Research, 2, 144-157.
71. Forment, J. V., Kaidi, A., & Jackson, S. P. (2012). Chromothripsis and cancer: causes and consequences of chromosome shattering. Nature Reviews Cancer, 12, 663-670.
72. Foraker, A. B., Camus, S. M., Evans, T. M., Majeed, S. R., Chen, C.-Y., et al. (2012). Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG. The Journal of Cell Biology, 198, 591-605.
73. Maher, C. A., Palanisamy, N., Brenner, J. C., Cao, X., Kalyana-Sundaram, S., et al. (2009). Chimeric transcript discovery by paired-end transcriptome sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 12353-12358.
74. Maher, J., Brentjens, R. J., Gunset, G., Riviere, I., & Sadelain, M. (2002). Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR[ζ]/CD28 receptor. Nature Biotechnology, 20, 70-75.
75. Blount, Z. D., Barrick, J. E., Davidson, C. J., & Lenski, R. E. (2012). Genomic analysis of a key innovation in an experimental Escherichia coli population. Nature, 489, 513-518.
76. Heng, H. H. (2009). The genome-centric concept: resynthesis of evolutionary theory. Bioessays, 31, 512-525.
77. Gillies, R. J., Verduzco, D., & Gatenby, R. A. (2012). Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nature Reviews Cancer, 12, 487-493.
78. Heng, H.H. (2013). 4-D Genomics: genome dynamics and constraint in evolution: New York: Springer